End-of-day quote
Taipei Exchange
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
51.4
TWD
|
+0.98%
|
|
+2.80%
|
+7.76%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,241
|
1,119
|
721.5
|
1,600
|
1,431
|
1,608
|
Enterprise Value (EV)
1 |
1,558
|
1,562
|
1,031
|
1,673
|
1,161
|
1,300
|
P/E ratio
|
8.76
x
|
14.9
x
|
17.4
x
|
12.3
x
|
6.78
x
|
13.5
x
|
Yield
|
6.18%
|
1.12%
|
2.02%
|
3.72%
|
7.07%
|
4.19%
|
Capitalization / Revenue
|
0.93
x
|
0.85
x
|
0.62
x
|
1.07
x
|
0.9
x
|
1.27
x
|
EV / Revenue
|
1.16
x
|
1.18
x
|
0.89
x
|
1.12
x
|
0.73
x
|
1.03
x
|
EV / EBITDA
|
6.58
x
|
9.79
x
|
8.22
x
|
7.03
x
|
4.3
x
|
7.03
x
|
EV / FCF
|
7.16
x
|
-35
x
|
7.63
x
|
6.98
x
|
6.78
x
|
15.7
x
|
FCF Yield
|
14%
|
-2.86%
|
13.1%
|
14.3%
|
14.7%
|
6.36%
|
Price to Book
|
2.35
x
|
2.14
x
|
1.31
x
|
2.4
x
|
1.43
x
|
1.58
x
|
Nbr of stocks (in thousands)
|
29,736
|
29,736
|
29,736
|
29,736
|
33,716
|
33,716
|
Reference price
2 |
41.75
|
37.62
|
24.26
|
53.80
|
42.45
|
47.70
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/29/21
|
3/29/23
|
3/29/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,339
|
1,321
|
1,160
|
1,497
|
1,598
|
1,262
|
EBITDA
1 |
236.6
|
159.6
|
125.5
|
237.8
|
270
|
184.9
|
EBIT
1 |
179.4
|
101.2
|
65.78
|
176.5
|
210
|
132.7
|
Operating Margin
|
13.4%
|
7.66%
|
5.67%
|
11.79%
|
13.14%
|
10.51%
|
Earnings before Tax (EBT)
1 |
178
|
99.11
|
57.3
|
173.7
|
249.6
|
155.7
|
Net income
1 |
143.6
|
75.72
|
41.78
|
130.8
|
196.2
|
120.2
|
Net margin
|
10.72%
|
5.73%
|
3.6%
|
8.74%
|
12.28%
|
9.52%
|
EPS
2 |
4.766
|
2.524
|
1.392
|
4.360
|
6.260
|
3.540
|
Free Cash Flow
1 |
217.5
|
-44.64
|
135.1
|
239.6
|
171.2
|
82.66
|
FCF margin
|
16.25%
|
-3.38%
|
11.65%
|
16.01%
|
10.71%
|
6.55%
|
FCF Conversion (EBITDA)
|
91.94%
|
-
|
107.67%
|
100.75%
|
63.4%
|
44.71%
|
FCF Conversion (Net income)
|
151.5%
|
-
|
323.4%
|
183.24%
|
87.25%
|
68.75%
|
Dividend per Share
2 |
2.580
|
0.4222
|
0.4902
|
2.000
|
3.000
|
2.000
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/29/21
|
3/29/23
|
3/29/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
316
|
443
|
310
|
73.2
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
270
|
308
|
Leverage (Debt/EBITDA)
|
1.337
x
|
2.778
x
|
2.469
x
|
0.3079
x
|
-
|
-
|
Free Cash Flow
1 |
218
|
-44.6
|
135
|
240
|
171
|
82.7
|
ROE (net income / shareholders' equity)
|
30.7%
|
14.4%
|
7.76%
|
21.4%
|
23.5%
|
11.9%
|
ROA (Net income/ Total Assets)
|
9.14%
|
5.08%
|
3.37%
|
9.23%
|
9.83%
|
5.73%
|
Assets
1 |
1,570
|
1,491
|
1,239
|
1,417
|
1,997
|
2,097
|
Book Value Per Share
2 |
17.80
|
17.60
|
18.60
|
22.50
|
29.80
|
30.30
|
Cash Flow per Share
2 |
3.970
|
3.180
|
3.260
|
4.190
|
12.40
|
12.60
|
Capex
1 |
19.6
|
27.1
|
24
|
20.1
|
31.6
|
31.6
|
Capex / Sales
|
1.47%
|
2.05%
|
2.07%
|
1.34%
|
1.98%
|
2.5%
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/29/21
|
3/29/23
|
3/29/23
|
3/15/24
|
|
1st Jan change
|
Capi.
|
---|
| +7.76% | 52.61M | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|